InsidersTradesSigma
立方制药 Stock: price and directors' dealings · China · SSE / SZSE (CSRC)
Follow the 立方制药 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on CN CN, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 立方制药 has logged 11 insider filings. Market capitalisation: €4.9bn. The latest transaction was disclosed on 21 June 2023 (Sale). Among the most active insiders: 汪琴. The full history is openly available.
11
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
11 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,973 of 25,821 companies
63.1
score / 100
Value53
Quality74
FCF yld2.6%
Earn yld4.6%
EV/EBITDA13.4x
ROE8.1%
Gross mgn65%
Net mgn11%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 21 June 2023
Declarations11 total
11 of 11 declarations